BACKGROUND: Drug-resistance mutations (DRAM) are frequently selected in patients with virological failure defined as viral load (pVL) above 500 copies/ml (c/mL). but few resistance data are available at low-level viremia (LLV). Our objective was to determine the emergence and evolution of DRAM during LLV in HIV-1-infected patients while receiving antiretroviral therapy (ART). METHODS:... https://www.roneverhart.com/Milwaukee-2981-20-M18-FUEL-4-1-2-in-6-in-Lock-On-Braking-Grinder-with-Slide-Switch/